187 related articles for article (PubMed ID: 7560854)
1. Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection.
Boadas J; Rodríguez-Espinosa J; Enríquez J; Miralles F; Martínez-Cerezo FJ; González P; Madoz P; Vilardell F
J Hepatol; 1995 Jun; 22(6):611-5. PubMed ID: 7560854
[TBL] [Abstract][Full Text] [Related]
2. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.
Marazuela M; García-Buey L; González-Fernández B; García-Monzón C; Arranz A; Borque MJ; Moreno-Otero R
Clin Endocrinol (Oxf); 1996 Jun; 44(6):635-42. PubMed ID: 8759175
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection in Spanish volunteer blood donors: HCV RNA analysis and liver disease.
Muñoz-Gómez R; García-Monzón C; García-Buey L; Lo Iacono O; Borque MJ; Garía-Sánchez A; Pajares JM; Moreno-Otero R
Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):273-7. PubMed ID: 8724030
[TBL] [Abstract][Full Text] [Related]
4. [Thyroid function and autoimmunity in 215 patients seropositive for the hepatitis C virus].
Nduwayo L; Bacq Y; Valat C; Goudeau A; Lecomte P
Ann Endocrinol (Paris); 1998 Apr; 59(1):9-13. PubMed ID: 9752392
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of thyroid autoantibodies in hepatitis C and hepatitis B infection in China.
Yang R; Shan Z; Li Y; Fan C; Li C; Teng W
Intern Med; 2011; 50(8):811-5. PubMed ID: 21498927
[TBL] [Abstract][Full Text] [Related]
7. A Prospective Observational Study of 42 Patients with COVID-19 infection and a History of Hepatitis C Virus Infection and Thyroid Disease with Follow-Up Thyroid Function and Autoantibody Testing.
Cristinel Badiu D; Popescu GC; Zgura A; Mercan Stanciu A; Dodot MD; Mehedintu C; Toma L; Razvan S; Bacinschi X; Haineala B
Med Sci Monit; 2021 Dec; 27():e935075. PubMed ID: 34969944
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.
Fernandez-Soto L; Gonzalez A; Escobar-Jimenez F; Vazquez R; Ocete E; Olea N; Salmeron J
Arch Intern Med; 1998 Jul; 158(13):1445-8. PubMed ID: 9665354
[TBL] [Abstract][Full Text] [Related]
9. [Hepatitis C virus infection and thyroid diseases].
Broussolle C; Steineur MP; Bailly F; Zoulim F; Trépo C
Rev Med Interne; 1999 Sep; 20(9):766-73. PubMed ID: 10522298
[TBL] [Abstract][Full Text] [Related]
10. A comparison of hepatitis C virus (HCV)-RNA and--antibody as markers of infection and predictors of infectivity.
Beardsley AM; LaBrooy JT; Rozen L; Gowans EJ
Aust N Z J Med; 1994 Apr; 24(2):182-7. PubMed ID: 8042947
[TBL] [Abstract][Full Text] [Related]
11. Thyroid autoantibodies and thyroid dysfunction during treatment with interferon-alpha for chronic hepatitis C.
Kiehne K; Kloehn S; Hinrichsen H; Gallwitz B; Mönig H
Endocrine; 1997 Jun; 6(3):231-4. PubMed ID: 9368677
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels.
Rossini A; Gazzola GB; Ravaggi A; Agostinelli E; Biasi L; Albertini A; Radaeli E; Cariani E
Transfusion; 1995 Feb; 35(2):108-11. PubMed ID: 7529954
[TBL] [Abstract][Full Text] [Related]
13. Liver disease in anti-hepatitis C virus-positive Norwegian blood donors.
Nordøy I; Schrumpf E; Elgjo K; Flesland O; Andersen Glende J; Orjasaeter H; Siebke JC
Scand J Gastroenterol; 1994 Jan; 29(1):77-81. PubMed ID: 8128181
[TBL] [Abstract][Full Text] [Related]
14. Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus-related infection.
Peoc'h K; Dubel L; Chazouillères O; Ocwieja T; Duron F; Poupon R; Johanet C
Am J Gastroenterol; 2001 Oct; 96(10):2978-83. PubMed ID: 11693336
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels.
Romeo R; Thiers V; Driss F; Berthelot P; Nalpas B; Brechot C
Transfusion; 1993 Aug; 33(8):629-33. PubMed ID: 7688157
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus antibodies and virus replication in asymptomatic blood donors.
Yuki N; Hayashi N; Hagiwara H; Naito M; Ohkawa K; Kasahara A; Fusamoto H; Ohtani S; Okubo Y; Kamada T
Vox Sang; 1994; 67(3):280-5. PubMed ID: 7532341
[TBL] [Abstract][Full Text] [Related]
17. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy.
Tran A; Quaranta JF; Benzaken S; Thiers V; Chau HT; Hastier P; Regnier D; Dreyfus G; Pradier C; Sadoul JL
Hepatology; 1993 Aug; 18(2):253-7. PubMed ID: 7687977
[TBL] [Abstract][Full Text] [Related]
19. Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease.
Colao A; Pivonello R; Faggiano A; Filippella M; Ferone D; Di Somma C; Cerbone G; Marzullo P; Fenzi G; Lombardi G
Clin Endocrinol (Oxf); 2000 Jul; 53(1):13-9. PubMed ID: 10931076
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test.
Serfaty L; Nousbaum JB; Elghouzzi MH; Giral P; Legendre C; Poupon R
Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
